UniSuper Management Pty Ltd Has $1.03 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

UniSuper Management Pty Ltd lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 611.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,695 shares of the company’s stock after buying an additional 11,771 shares during the period. UniSuper Management Pty Ltd’s holdings in Henry Schein were worth $1,034,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of HSIC. Boston Partners boosted its position in shares of Henry Schein by 144.1% during the fourth quarter. Boston Partners now owns 2,637,429 shares of the company’s stock worth $199,393,000 after buying an additional 1,556,831 shares during the period. Norges Bank acquired a new position in shares of Henry Schein during the fourth quarter worth about $111,715,000. Nuance Investments LLC acquired a new position in shares of Henry Schein during the fourth quarter worth about $103,446,000. Fiduciary Management Inc. WI boosted its position in Henry Schein by 17.1% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after purchasing an additional 333,855 shares during the last quarter. Finally, KBC Group NV boosted its position in Henry Schein by 163.5% during the fourth quarter. KBC Group NV now owns 521,964 shares of the company’s stock valued at $39,518,000 after purchasing an additional 323,901 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of NASDAQ HSIC traded up $0.30 during trading hours on Wednesday, reaching $70.29. 1,425,823 shares of the stock were exchanged, compared to its average volume of 1,105,807. The firm has a market capitalization of $9.00 billion, a price-to-earnings ratio of 23.75, a P/E/G ratio of 1.75 and a beta of 0.87. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63. The stock’s fifty day simple moving average is $68.28 and its 200 day simple moving average is $71.92.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.21 earnings per share. Sell-side analysts predict that Henry Schein, Inc. will post 5.16 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently commented on HSIC. Robert W. Baird raised Henry Schein from a “neutral” rating to an “outperform” rating and increased their price target for the company from $81.00 to $92.00 in a research report on Monday. Barrington Research reissued an “outperform” rating and set a $92.00 price target on shares of Henry Schein in a research report on Friday, July 5th. Piper Sandler reissued an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday. Finally, Evercore ISI reduced their price target on Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research report on Tuesday, July 9th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $81.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.